Revelation Biosciences
REVB
14 hedge funds and large institutions have $57.5M invested in Revelation Biosciences in 2021 Q3 according to their latest regulatory filings, with 3 funds opening new positions, increasing their positions, 1 reducing their positions, and 2 closing their positions.
50% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 2
12% more capital invested
Capital invested by funds: $51.3M → $57.5M (+$6.25M)
8% more funds holding
Funds holding: 13 → 14 (+1)
0% less ownership
Funds ownership: 0% → 0% (-0%)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MSU
Mizuho Securities USA
New York
|
+$6.07M |
| 2 |
GCL
Glazer Capital LLC
New York
|
+$4.05M |
| 3 |
FTCM
Fir Tree Capital Management
New York
|
+$2.02M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PAMP
Polar Asset Management Partners
Toronto,
Ontario, Canada
|
-$4.02M |
| 2 |
BFM
Boothbay Fund Management
New York
|
-$4.01M |
| 3 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
-$2.02M |
| 4 |
PC
Periscope Capital
Toronto,
Ontario, Canada
|
-$451K |
| 5 |
KPF
K2 Principal Fund
Toronto,
Ontario, Canada
|
-$267K |
REVB Hedge Fund Activity: Q3 2021 in Review
14 of the 5,726 institutional investors tracked by Wall St. Rank reported a position in Revelation Biosciences (REVB) for Q3 2021, worth a combined $57.5M — up 12% from $51.3M a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new REVB positions and 2 closed out — a net gain of 1 holder — while 0 added to existing stakes and 1 trimmed.
The largest buyer was Mizuho Securities USA, opening a new position worth an estimated $6.07M. The largest seller was Polar Asset Management Partners, exiting entirely with an estimated $4.02M sold.
- 14 institutional investors held Revelation Biosciences (REVB) as of Q3 2021, up from 13 in Q2 2021.
- Funds reported $57.5M of Revelation Biosciences stock for Q3 2021, up 12% quarter-over-quarter.
- 3 funds opened new Revelation Biosciences positions in Q3 2021 and 2 closed out, a net change of +1 holder.
- The largest Revelation Biosciences buyer in Q3 2021 was Mizuho Securities USA, an estimated $6.07M added.
- The largest Revelation Biosciences seller in Q3 2021 was Polar Asset Management Partners, an estimated $4.02M sold.
Based on aggregated 13F filings for Q3 2021.